Contributions of observational cohort studies in systemic lupus erythematosus: The University of Toronto Lupus Clinic experience

Rheumatic Disease Clinics of North America

Volumn 31, Issue 2, 2005, Pages 211-221

  Urowitz, Murray B ^a,b   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AVASCULAR NECROSIS; BONE NECROSIS; CANADA; CHRONIC DISEASE; COHORT ANALYSIS; ETHICS; EXPERIENCE; HUMAN; KIDNEY DISEASE; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPATHY; REVIEW; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UNIVERSITY;

COHORT STUDIES; EVIDENCE-BASED MEDICINE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; ONTARIO;

EID: 19544390707     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.01.008     Document Type: Review

References (53)

1. Preventive Services Task Force Guide to clinical preventive services: report of the US Preventive Services Task Force 2nd edition 1996 Williams and Wilkins Baltimore (MD)
2. A.R. Feinstein An additional basic science for clinical medicine: IV. The development of Clinimetrics Ann Intern Med 99 6 1983 843 848
3. P. Lee, M.B. Urowitz, and A.A.M. Bookman SLE: a review of 110 cases with particular reference to lupus nephritis, CNS manifestations, infections. Aseptic necrosis and prognosis Q J Med 46 1977 1 32
4. D.D. Gladman, D.R. Koh, and M.B. Urowitz Lost to follow-up study in SLE Lupus 9 2000 363 367
5. M.B. Urowitz, D.D. Gladman, and E.S. Tozman Lupus activity criteria count J Rheumatol 11 1984 783 787
6. C. Bombardier, D.D. Gladman, and M.B. Urowitz The development and validation of the SLE Disease Activity Index (SLEDAI) Arthritis Rheum 35 1992 630 640
7. D.D. Gladman, C.H. Goldsmith, and M.B. Urowitz Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation J Rheumatol 21 1994 1468 1471
8. G. Hawker, S. Gabriel, and C. Bombardier A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus (SLE) J Rheumatol 20 1993 657 660
9. D.D. Gladman, D. Ibañez, and M.B. Urowitz SLE Disease Activity Index 2000 J Rheumatol 29 2002 288 291
10. D. Ibanez, M.B. Urowitz, and D.D. Gladman Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus J Rheumatol 30 2003 1977 1982
11. Ibañez D., Urowitz M.B., Gladman D.D. Disease activity over time (adjusted mean SLEDAI) predicts mortality and damage in SLE
12. D. Gladman, E. Ginzler, and C. Goldsmith The development and initial validation of the SLICC/ACR damage index for SLE Arthritis Rheum 39 1996 363 369
13. D. Gladman, M.B. Urowitz, and C. Goldsmith The reliability of the SLICC/ACR damage index for SLE Arthritis Rheum 40 1997 809 813
14. D.D. Gladman, M. Urowitz, and P. Fortin Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) Conference on Assessment of Lupus Flare and Quality of Life Measures in SLE (workshop report) J Rheumatol 23 1996 1953 1955
15. M.B. Urowitz, D.D. Gladman, A. Chalmers, and M.A. Ogryzlo Nail lesions in systemic lupus erythematosus J Rheumatol 5 1978 441 447
16. T. Abel, D.D. Gladman, and M.B. Urowitz Neuropsychiatric lupus J Rheumatol 7 1980 325 333
17. J.A.J. Kovacs, M.B. Urowitz, and D.D. Gladman Single photon emission computerized tomography (SPECT) in neuropsychiatric SLE (NPSLE) J Rheumatol 22 1995 1247 1253
18. M.H. Miller, M.B. Urowitz, and D.D. Gladman The liver in systemic lupus erythematosus Q J Med 53 1984 401 409
19. M.H. Miller, M.B. Urowitz, and D.D. Gladman The significance of thrombocytopenia in systemic lupus erythematosus Arthritis Rheum 26 1983 1181 1186
20. M.B. Urowitz, D.D. Gladman, and V.T. Farewell Lupus and pregnancy studies Arthritis Rheum 36 1993 1392 1397
21. A.A.M. Bookman, M.B. Urowitz, and B.E. Koehler The bimodal pattern of mortality in systemic lupus erythematosus (SLE) [abstract] J Rheumatol 1 1974 57
22. M.B. Urowitz, A.A.M. Bookman, and B.E. Koehler The bimodal mortality in systemic lupus erythematosus Am J Med 60 1976 221 225
23. L. Rubin, M.B. Urowitz, and D.D. Gladman Mortality in SLE. The bimodal pattern revisited Q J Med 55 1985 87 98
24. M. Abu-Shakra, M.B. Urowitz, and D.D. Gladman Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death J Rheumatol 22 1995 1259 1264
25. I.N. Bruce, D.D. Gladman, and M.B. Urowitz Premature atherosclerosis in SLE Rheum Dis Clin North Am 26 2000 257 278
26. M.B. Urowitz, D. Ibañez, and D.D. Gladman Atherosclerotic vascular events (AVE) in a single large lupus cohort: prevalence and risk factors Arthritis Rheum 50 Suppl 9 2004 S594
27. M.B. Urowitz, D.D. Gladman, and I. Ibañez Atherosclerotic vascular events in a risk factor study from a single center: prevalence and risk factors Arthritis Rheum 50 Suppl 9 2004 S594
28. M.B. Urowitz, D.D. Gladman, and M. Abu-Shakra Mortality studies in systemic lupus erythematosus. Results from a single centre. III. Improved survival over 24 years J Rheumatol 24 1997 1061 1065
29. E. Tozman, M.B. Urowitz, and D.D. Gladman Prolonged complete remission in SLE Ann Rheum Dis 41 1982 39 40
30. Urowitz M.B., Feletar M., Bruce I.N., et al. Prolonged remission in systemic lupus erythematosus. J Rheumatol, in press
31. D.D. Gladman, V. Chaudhry-Ahluwalia, and D. Ibanez Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus J Rheumatol 28 10 2001 2226 2229
32. D.D. Gladman, M.B. Urowitz, and V. Chaudhry-Ahluwalia Predictive factors for symptomatic osteonecrosis in systemic lupus erythematosus J Rheumatol 28 2001 761 765
33. R. Prasad, D. Ibanez, and D.D. Gladman Corticosteroid dose in early SLE is a determining factor for avascular necrosis: a nested case control study of inception patients Arthritis Rheum 50 2004 4090
34. D.D. Gladman, M.B. Urowitz, and E. Cole Kidney biopsy in SLE I: clinical-morphologic correlations Q J Med 73 1989 1125 1133
35. P. Rahman, D.D. Gladman, and D. Ibanez Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus Lupus 10 2001 418 423
36. J. McLaughlin, D.D. Gladman, and M.B. Urowitz Renal biopsy in SLE. II: Survival analyses according to biopsy results Arthritis Rheum 34 1991 1268 1273
37. J.R. McLaughlin, C.B. Bombardier, and V.T. Farewell Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables Arthritis Rheum 37 1994 559 567
38. S. Bajaj, L. Albert, and D.D. Gladman Serial renal biopsy in systemic lupus erythematosus J Rheumatol 27 2000 2822 2826
39. I.N. Bruce, D.D. Gladman, and M.B. Urowitz Factors associated with refractory renal disease in patients with SLE: the role of patient nonadherence Arthritis Care Res 13 2000 406 408
40. V. Bruto, M.B. Urowitz, and D.D. Gladman Neurocognitive abnormalities in offspring of mothers with SLE Arthritis Rheum 48 Suppl 9 2003 S182
41. D.D. Gladman, M.B. Urowitz, and E.C. Keystone Serologically active clinically quiescent SLE-a discordance between clinical and serological features of SLE Am J Med 66 1979 210 215
42. B. Walz-Leblanc, D.D. Gladman, and M.B. Urowitz Serologically active clinically quiescent SLE J Rheumatol 21 1994 2239 2241
43. D.D. Gladman, N. Hirani, and D. Ibañez Clinically active serologically quiescent (CASQ) SLE J Rheumatol 30 2003 1960 1962
44. S.H. Kreidstein, M.B. Urowitz, and D.D. Gladman Hormone replacement therapy in SLE J Rheumatol 24 1997 2149 2152
45. M.D. Lockshin, E. Reinitz, and M.L. Druzin Lupus pregnancy. Case control prospective study demonstrating absence of lupus exacerbation during or after pregnancy Am J Med 77 1984 893 898
46. M.B. Urowitz, and D. Ibanez All SLICC members. Systemic Lupus International Collaborating Clinics (SLICC) inception cohort registry to study risk factors for atherosclerosis Arthritis Rheum 50 Suppl 9 2004 S594
47. C. Drenkard, A.R. Villa, and C. Garcia-Padilla Remission of systemic lupus erythematosus Medicine (Baltimore) 75 1996 88 98
48. J. Golbus, and W.J. McCune Lupus nephritis. Classification, prognosis, immunopathogenesis and treatment Rheum Dis Clin North Am 20 1994 213 242
49. S.D. Denburg, J.A. Denburg, and R.M. Carbotte Cognitive deficits in systemic lupus erythematosus Rheum Dis Clin North Am 19 1993 815 831
50. J.G. Hanly, J.D. Fisk, and G. Sherwood Clinical course of cognitive dysfunction in systemic lupus erythematosus J Rheumatol 21 10 1994 1825 1831
51. P.H. Schur, and J. Sandson Immunologic factors and clinical activity in lupus erythematosus N Engl J Med 278 1968 533 538
52. R.W. Lightfoot Jr, and G.R.V. Hughes Significance of persisting serologic abnormalities in SLE Arthritis Rheum 19 1976 837 843
53. E.J. Ter Borg, G. Horst, and E.J. Hummel Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study Arthritis Rheum 33 1990 624 643